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ABSTRACT
A structured questionnaire concerning hospital
infection control (IC) organisation and initiatives
was sent to 45 hospitals in Algeria, Cyprus, Egypt,
Jordan, Lebanon, Libya, Malta, Morocco, Tunisia
and Turkey. Hospitals bordering the eastern
Mediterranean appeared to have more estab-
lished IC infrastructures than southern Mediter-
ranean hospitals. However, there were no
signiﬁcant differences among hospitals in the
two regions in surveillance activities, the presence
of an antibiotic policy or feedback of resistance
data to prescribers, all of which were at a low
level. Only a minority of hospitals had published
antimicrobial treatment guidelines or gave
feedback on antimicrobial resistance data to
prescribers.
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Incidents of healthcare-associated infection (HAI),
particularly those occurring in hospitals, are
among the most common adverse events in
healthcare settings [1]. The impact of HAI appears
to be particularly acute within the Mediterranean
area, where an additional problem is posed by
antimicrobial resistance in key pathogens [2,3].
Multiresistance appears to be prevalent in
hospitals in the southern and eastern Mediterra-
nean regions, where proportions of methicillin-
resistant Staphylococcus aureus (MRSA) ranging
from 17.8% to 66.1%, and resistance rates to third-
generation cephalosporins within Escherichia coli
of up to 76.6%, have been reported [4]. It is now
accepted that a structured hospital infection con-
trol (IC) programme, incorporating a designated
infection control doctor (ICD) and infection con-
trol nurse (ICN), together with a well-designed
surveillance system, can reduce infection rates by
up to 32% [5]. Despite the importance of nosoco-
mial infections in the Mediterranean area, infor-
mation concerning interventions and activities
aimed at control of HAI is limited and pertains
mainly to certain individual European countries
in the north of the region [6–8].
The aim of the present study was to obtain
more information concerning the status of IC
initiatives in hospitals in southern and eastern
Mediterranean countries. The study was under-
taken as part of the DG Research IncoMed-funded
project Antibiotic Resistance Surveillance and
Control in the Mediterranean Region (ARMed)
(http://www.slh.gov.mt/armed; http://www.
eurosurveillance.org/ew/2004/040212.asp#5). A
questionnaire was compiled with the help of
the project coordinators from the participating
countries, who also piloted the draft in their
institutions. The ﬁnal version was disseminated
electronically during February 2005 to 45 participa-
ting hospitals. The questionnaire was completed by
an individual who was identiﬁed by the project
coordinator in each country as having a particular
interest or involvement in IC within his or her
hospital. Similarly, the participating hospitals were
selected by the individual project coordinators as
institutions typical of secondary or tertiary facilities
in each country. The questionnaire queried the
status of the IC programme, the hospital’s require-
ments for the presence of a functional ICCommittee
(ICC), and whether ICDs and ICNs had been
appointed, and asked for information concerning
training and job descriptions. Another important
section focused on HAI surveillance within each
institution, the availability of documented guide-
lines for prevention and control of HAI, including
multiresistant organisms (MRO), the presence of
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antibiotic prescribing guidelines, andwhether feed-
back on a hospital’s resistance rates was provided
to prescribers and key stakeholders. Data collected
were checked, coded according to an agreed pre-
determined system, and then analysed using Inter-
cooled STATA v. 6 (Stata Corporation, College
Station, TX, USA) and MS Excel. The z-test and
95% CIs were used to determine statistically signi-
ﬁcant differences.
All 45 hospitals completed the questionnaire,
including 28 hospitals bordering the eastern
Mediterranean (Cyprus, Egypt, Jordan, Lebanon,
Turkey) with a median bed size of 606 (inter-quar-
tile range (IQR) 350–903) beds, and 17 hospitals
bordering the southern Mediterranean (Algeria,
Libya, Malta, Morocco, Tunisia) with a median
size of 550 (IQR 258–750) beds. University and
tertiary care institutions comprised 75% of the
eastern participants and all but one of the hospi-
tals in the south. Bed-occupancy ranged from
71% to 120% (median 83.5%, IQR 71.9)91.0%).
IC programmes appeared to be somewhat more
advanced in eastern Mediterranean countries,
particularly with respect to the reported fre-
quency of ICDs and ICNs (Table 1). Medical and
nursing professionals trained and entrusted with
IC initiatives were found signiﬁcantly more com-
monly in the eastern hospitals (ICDs, 78.6% vs.
47.1%, p < 0.05; ICNs, 82.1% vs. 58.8%, p < 0.05).
Not only did the questionnaire identify major
differences in IC personnel among the participat-
ing hospitals in the two regions, but it also
revealed smaller differences in IC outputs and
interventions. Written policies and guidelines
were generally absent in most of the participating
hospitals. This was particularly true in the south-
ern Mediterranean hospitals, of which only 5.9%
had endorsed IC polices and documentation.
Only a minority of hospitals (35.3% in southern
and 25% in eastern hospitals) had published
antimicrobial treatment guidelines, and feedback
of antimicrobial resistance data to prescribers was
undertaken in 41.2% of southern and 38.7% of
eastern Mediterranean hospitals.
The number of hospitals surveyed was relat-
ively small, but they were chosen by national
experts in the ﬁeld to be as representative as
possible of hospitals in each country. It is, of
course, unwise to extrapolate this study to the
whole south-eastern Mediterranean region. How-
ever, this ﬁrst attempt to assess the situation in
the region indicated signiﬁcant variation in the
development of IC organisation and initiatives
among the participating hospitals. It was also
evident that most aspects of IC are only at an
early stage of development. This is not surpri-
sing as these countries are, to a varying extent,
still developing socio-economic, educational and
healthcare infrastructures towards levels com-
parable with those of their western counterparts.
In developing countries, substantial deﬁciencies
in healthcare quality and delivery are invariably
the result of insufﬁcient budgets, low salaries
for healthcare personnel, and the diversion of
resources to areas of higher priority or which
produce more tangible outcomes [9].
Nosocomial infections constitute an even high-
er monetary burden for countries in which the
average hospital cost for a single HAI may reach
the equivalent of the gross national income (GNI)
per capita [10]. The cost-effectiveness of IC is
therefore even greater than that in developed
countries. Targeted IC interventions have been
shown to be possible and cost-effective, even in
Table 1. Reported frequency of elements recommended for infection control (IC) programmes among the eastern and
southern Mediterranean hospitals participating in the survey
Eastern hospitals (n = 28) Southern hospitals (n = 17)
p valuen % (95% CI) n % (95% CI)
IC committee 25 89.29 (77.84, 100) 8 47.06 (23.33, 70.79) 0.0009
IC team 21 75.00 (58.96, 91.04) 8 47.06 (23.33, 70.79) 0.0287
IC doctors (ICD) 22 78.57 (63.37, 93.77) 8 47.06 (23.33, 70.79) 0.0150
ICD job description 15 53.57 (35.10, 72.04) 5 29.41 (7.75, 51.07) 0.0571
ICD training programme 16 57.14 (38.81, 75.47) 6 35.29 (12.57, 58.01) 0.0778
IC nurses (ICN) 23 82.14 (67.95, 96.33) 10 58.82 (35.42, 82.22) 0.0427
ICN job description 18 64.29 (46.54, 82.04) 6 35.29 (12.57, 58.01) 0.0301
ICN training programme 18 64.29 (46.54, 82.04) 6 35.29 (12.57, 58.01) 0.0294
Surveillance 18 64.29 (46.54, 82.04) 8 47.06 (23.33, 70.79) 0.1292
IC guidelines 8 28.57 (11.84, 45.30) 1 5.88 (0, 17.06) 0.0329
Antibiotic policy 7 25.00 (8.96, 41.04) 6 35.29 (12.57, 58.01) 0.2296
Feedback of antimicrobial
resistance surveillance data 10 35.71 (17.96, 53.46) 7 41.18 (17.78, 64.58) 0.3557
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settings with limited resources [11], and partic-
ularly when interventions are adapted for local
circumstances [12]. Previous ARMed project data
concerned national IC initiatives, and suggested
that signiﬁcant progress is necessary at a national
level to foster improvement [13]. In a region
where administrative endorsement is critical for
programmes to be successful, it is vital that IC
initiatives in individual hospitals are supported at
governmental and regulatory levels. It can be
strongly argued that a comprehensive pro-
gramme for preventing nosocomial infections
within southern and eastern Mediterranean hos-
pitals would pay for itself by reducing bed-days
lost to HAI, and would generate other direct and
indirect beneﬁts to patients in terms of reduced
mortality and morbidity, and to families and care-
givers as a result of improved quality of care,
thereby making a large impact on the whole of
society [14].
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